Recent Headlines
Within Biotechnology
MedSource Awarded Services Contract for a Phase I Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Clinical Trial
Houston-based Contract Research Organization (CRO) to manage three-year Phase I study - May 17, 2009 - MedSource
Red Cedar Technology Releases HEEDS Professional 5.3
New interfaces for LS-DYNA and Abaqus streamline the optimization process for engineers. - May 16, 2009 - Red Cedar Technology
MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project... - May 15, 2009 - MedSource
AnaSpec Introduces Biotin Labeled Beta-Amyloid GO™ Peptides
AnaSpec has introduced a line of b-amyloid peptides labeled with biotin (N or C-terminal biotin labels) as well as N-terminal biotin labeled b-amyloid peptides with a fluorescein label on the C-terminus. - May 15, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies Appoints Chief Technology Officer
At a recent press conference, Sustainable Now Technologies (SNT) announced the appointment of their third officer. - May 15, 2009 - Sustainable Now Technologies
Baxa Corporation and CriticalPoint™ Training Rated “Excellent” in Customer Satisfaction
Baxa Corporation and CriticalPoint, LLC, announce positive results for the CriticalPoint training program from the Pharmacy Purchasing and Products 2nd annual national survey. This high level of user satisfaction can be attributed to the program’s simple Internet access, high- written by industry experts and the ease of tracking employee training through its Learning Management System. - May 13, 2009 - Baxa Corporation
Sustainable Now Technologies Launches Website
Green Technologies Corporation, Sustainable Now Technologies (SNT), announces the launch of it's official company website. - May 13, 2009 - Sustainable Now Technologies
AnaSpec Launches Z-Fish™ Antibodies
AnaSpec has announced the launch of the Z-Fish™ product line of antibodies in order to address the growing needs of the research community for zebrafish specific antibodies, peptides and other products. - May 09, 2009 - AnaSpec, EGT Group
Indigene Launches Memoryl in Cyprus
Indigene Pharmaceuticals, A US based bio-pharmaceuticals company, has announced the launch of its highest selling brand Memoryl in Cyprus in association with M S Jacovides group. “We are delighted to launch Memoryl in Cyprus in association with M S Jacovides group and we are sure that our... - May 09, 2009 - Indigene Pharmaceuticals. Pvt. Ltd
Special DNA Testing Offered in Response to Swine Influenza Epidemic
Personal genome company, BioResolve, Inc has introduced a DNA testing service that reveals an individual's innate resistance or vulnerabilities to infectious diseases, such as swine flu. The final report states an individual's ratio of surviving a worldwide pandemic with respect to the average human, and looks into all types of infectious diseases. - May 08, 2009 - BioResolve, Inc.
CodonCode Corporation Announces Free License Program for DNA Sequence Assembly Software
Free licenses for CodonCode Aligner, a leading software program for DNA sequence assembly and analysis, will be made available to selected applicants under CodonCode Corporation's new License Grant Program. - May 07, 2009 - CodonCode Corporation
Bioo Scientific Corp. Receives NIH Grant for the Development of Novel Anti-Viral Therapeutics
Bioo Scientific received a $1.25 million grant from the National Institutes of Health to develop new anti-viral therapeutics. - May 07, 2009 - Bioo Scientific
Chief Technology Officer for Baxa Corporation’s Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida
Dennis Tribble, PharmD, will speak on “Upstream Processing of Medications” at this year’s unSUMMIT, May 6-8, at the Tampa Marriott Waterside Hotel and Marina. The presentation describes the infrastructure necessary for a successful Bar Code Medication Administration (BCMA) system and is being held today, Wednesday, May 6, 2009, at 2:20 p.m. Participants are eligible for one contact hour of Pharmacy Continuing Education (CEU). - May 06, 2009 - Baxa Corporation
Functional Genetics Highlights Progress in the Development of Broad-Spectrum Antiviral at the 22nd International Conference on Antiviral Research
Functional Genetics, Inc. today announced that two platform presentations and three poster abstracts on progress being made in its broad-spectrum antiviral programs will be presented during the International Conference on Antiviral Research in Miami, FL from May 4 to 7. “The development of... - May 06, 2009 - Functional Genetics, Inc.
AnaSpec Introduces New SensoLyte Anti-Human MOG (1-125) IgG ELISA Kit
AnaSpec has announced the release of the newest addition to its Anti-MOG ELISA assay kit series – the SensoLyte Anti-Human MOG (1-125) IgG Quantitation ELISA Kit. This kit, along with previously featured SensoLyte Anti-Mouse MOG (1-125) and SensoLyte Anti-Rat MOG (1-125) IgG ELISA assay kits... - May 03, 2009 - AnaSpec, EGT Group
ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.
ENCO Analytix, Inc. announced today that effective immediately the company name will change to ENCO Pharmaceutical Development, Inc. - May 03, 2009 - Enco Pharmaceutical Development, Inc.
Bioo Scientific Launches In Vivo siRNA Delivery Reagent
Bioo Scientific Developed MaxSuppressor In Vivo RNA-LANCEr II to Optimize in vivo RNAi. - May 01, 2009 - Bioo Scientific
AnaSpec Launches New Headquarters in Fremont, California
Today AnaSpec announced the launch of its new headquarters in Fremont, California. Rapidly expanding over the past 16 years, AnaSpec has graduated to a state-of-the-art facility designed from the ground up for the very highest levels of lab and R&D production. The 44,010 square foot facility... - April 30, 2009 - AnaSpec, EGT Group
New Scientific Publication Explains How LDB B-30892 Inhibits the Cytotoxic Effects of Clostridium difficile
LacPro Industries LLC, a probiotic-based biotherapeutics company, announces a publication in the peer-reviewed scientific journal, Gut Pathogens, entitled, "Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells.” In this scientific publication, the research team explains the published in vitro research demonstrating the beneficial effect of LacPro's proprietary probiotic strain. - April 28, 2009 - LacPro Industries LLC
Strand Life Sciences Solution for Bioinformatics Challenges in NGS
New software solution for the analysis of data from Next-Generation Sequencing (NGS) experiments. - April 28, 2009 - Strand Life Sciences Pvt. Ltd.
Baxa Corporation Wins Two 2009 Colorado BMA Gold Key Awards
Baxa Corporation campaigns awarded 2009 Business Marketing Association Gold Key Awards for Product Literature and Websites/Search Engine Marketing. The BMA Gold Key Awards are one of Colorado’s most highly acclaimed marketing competitions, with entries reviewed by a panel of six independent judges from across the US. - April 27, 2009 - Baxa Corporation
Colorado BioScience Association Names Rick Jory Board Chair, Announces 2009 Sponsors and Appoints Seven New Board Members
Rick Jory, CEO of Sandhill Scientific, Inc., Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2009 annual meeting yesterday. Jory assumes chairperson responsibilities from Jack Wheeler, MicroPhage, Inc. In other action, seven new members were named to the CBSA board of directors. - April 23, 2009 - Colorado BioScience Association
LacPro Industries, LLC Named Techpoint Mira Award Finalist
Fort Wayne-based LacPro, a biotherapeutic company developing a product for Clostridium difficile Infection, has been named a finalist for Innovation of the Year. - April 22, 2009 - LacPro Industries LLC
Baxa ‘Ecological’ Program Promotes Benefits of Recycling
Commitment to ‘green’ activities at Baxa Corporation celebrates Earth Day 2009 while providing reduced costs and workplace benefits. Historically, Baxa has chosen product designs and raw materials that reduce waste and improve patient safety and minimize environmental impact. More recently, the company has introduced specific initiatives for reducing its environmental impact and advancing its environmental stewardship. - April 20, 2009 - Baxa Corporation
MicroTransponder CEO Will Rosellini to Testify Before the U.S. House of Representatives Concerning Neurotechnology
CEO Will Rosellini will testify before the U.S. House of Representatives regarding the Federal SBIR program on Wednesday, April 22. SBIR awards to MicroTransponder have funded neurotechnology research for TBI, Tinnitus, and PTSD resulting in potential new treatments for soldiers. - April 19, 2009 - MicroTransponder Inc.
Quintiles Named to Top 25 Canadian Employers List
Quintiles has been recognized by the Great Place to Work® (GPTW) Institute Canada as one of the top 25 companies to work for in the country. It is the first time Quintiles has made the Canadian GPTW list since the Institute’s awards were launched there in 2005. Quintiles is the... - April 17, 2009 - Quintiles
AnaSpec Introduces New HiLyte Fluor™ 594 Labeled Secondary Antibodies & Streptavidin
AnaSpec has introduced a line of secondary antibodies and streptavidin conjugated to the newest member of the HiLyte Fluor™ family - HiLyte Fluor™ 594 (Ex/Em=593/616 nm). Using optimal fluorophore/protein labeling ratio, these HiLyte Fluor™ 594-IgG conjugates exhibit high... - April 15, 2009 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte Luminescent Peroxidase Assay Kits
AnaSpec has introduced two new luminescent read-out assay kits for determining peroxidase activity – the SensoLyte Luminescent Peroxidase Assay Kit and the SensoLyte Luminescent Peroxidase ELISA Assay Kit. - April 12, 2009 - AnaSpec, EGT Group
AnaSpec Introduces Series of Cell Penetrating Peptides (CPP)
AnaSpec has CPPs such as (Arg)9, Antennapedia, TAT and others. Offerings include green fluorescent labeled (e.g. FAM or FITC) CPP, red labeled (e.g. TAMRA), Cys conjugated CPPs or Cys(Npys) conjugated CPP. - April 08, 2009 - AnaSpec, EGT Group
Baxa Corporation Gets Social with Facebook and LinkedIn
Colorado Medical Device Company, Baxa Corporation, invites customers to just “have fun” and use social media tools to connect and share experience on Facebook and LinkedIn. More and more healthcare facilities, medical device companies and hospitals are using social media as a powerful tool to interact with their customers on a more personal level – complementing their more formal Web site content. - April 06, 2009 - Baxa Corporation
World's Leading Scientists Meet to Examine Barriers for Stem Cell Therapies to Cure Spinal Cord Injury
Following President Barack Obama's decision to lift the ban on federal funding for embryonic stem cell research, medical and scientific experts will converge at the University of Georgia to discuss how recent advances in stem cell research can be translated into cures for spinal cord injuries. The... - March 31, 2009 - Bedford Stem Cell Research Foundation
Massachusetts Scientists Make Stem Cell Discovery
Cell Multiplication Controlled by a Surprising set of Genes. Stem cell researcher Dr. Ann Kiessling has discovered that early human embryo cells express CLOCK, and other circadian genes, that other human cells growing in laboratories did not. This was a surprise. According to Professor Jose Cibelli of Michigan State University, "This is a seminal paper. I am sure we will be referring back to it 10, 20 years from now." - March 30, 2009 - Bedford Stem Cell Research Foundation
MoBiTec GmbH, Germany, is Offering Photochromic Fluorescent Protein EosFP
The Green-to-Red switchable, photochromic Fluorescent Protein „EosFP“ offers advantageous applications in Molecular Cell Biology, and is now available through the German biotech company MoBiTec GmbH. With violet light, single cells in an EosFP marked (green) cell population can be switched to red, so that their fate can be followed selectively, for example in embryonic cell differentiation. Alternatively, a particular compartment within an EosFP marked (green) cell can be switched to red. - March 25, 2009 - MoBiTec GmbH
AnaSpec’s ClearPoint™ Peptides Win Best New Product Award
AnaSpec’s ClearPoint™ Peptides were awarded the Best New Product Award in the category of Biological Samples and Reagents at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference which was held in San Francisco, CA from February 25-27. By spiking protein tryptic digests... - March 25, 2009 - AnaSpec, EGT Group
Colorado Bioscience Association Teams with Twenty-Six National & State Partners to Launch the ‘We Work for Health’ Initiative in Colorado
The Colorado BioScience Association is partnering with twenty-six national and state entities to announce the ‘We Work For Health’ initiative in Colorado. The launch event – Saving Lives, Creating Jobs -- occurs today at University of Colorado Denver, Anschutz Medical Campus in Aurora. U.S. Senator Michael Bennet is the special guest speaker. - March 20, 2009 - Colorado BioScience Association
Cerulean’s John Avellanet Interviewed on 21 CFR Part 11, Computer Validation, and His SmarterCompliance FDA Advisory Program in GxP Lifeline
Independent FDA compliance expert, John Avellanet, was recently interviewed on how companies can save money by taking advantage of where the FDA is headed on 21 CFR Part 11 and computer virtualization. - March 20, 2009 - Cerulean Associates LLC
AnaSpec Offers Calcein AM for Live Cell Staining
AnaSpec is pleased to offer Calcein, AM, a cell-permeant and non-fluorescent compound that is widely used for determining cell viability. Non-fluorescent Calcein, AM in live cells is hydrolyzed by intracellular esterases into the strongly green fluorescent anion calcein, and is retained in the... - March 18, 2009 - AnaSpec, EGT Group
MoBiTec GmbH Closes Distribution Agreement for Lactococcus lactis Gene Expression System with NIZO Food Research
NIZO food research has developed a Gram positive gene expression system making use of Lactococcus lactis and its regulation mechanism for the production of the antibiotic peptide nisin, the NIsin Controlled gene Expression system (NICE). The NICE system is already used as a dedicated expression system by many labs all around the world. With NICE, MoBiTec expands its rich portfolio of non-E. coli based expression systems. - March 15, 2009 - MoBiTec GmbH
AnaSpec Launches New Anti-Keratin 10, 13 and 14 Antibodies
AnaSpec has announced type I acidic keratin antibodies (keratin –10, -13 and -14) have been tested in applications such as western blots or IHC. - March 15, 2009 - AnaSpec, EGT Group
AnaSpec Launches New SensoLyte® Rh110 Long Wavelength Plasmin Activity Assay Kit
AnaSpec is pleased to announce the release of another long wavelength protease assay – the SensoLyte® Rh110 Plasmin Activity Assay Kit (Ex/Em=496 nm/520 nm). - March 14, 2009 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with BioPike, LLC
AnaSpec, Inc. and BioPike, LLC today announced a non-exclusive distributor agreement that will allow BioPike, LLC to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased to... - March 13, 2009 - AnaSpec, EGT Group
Sleep Machine Provides Magnetic Solution for Poor Quality Sleep
The Sleep on Command™ Sleep Machine offers consumers a natural way to fall asleep faster, stay asleep longer and wake up feeling more rejuvenated than ever before. The Sleep on Command™ Sleep Machine uses technology based upon natural Earth generated frequencies. These naturally occurring frequencies correlate perfectly with the mind’s stress free brain-wave spectrum. The lowest end of that spectrum correlates perfectly with deep Delta-rhythm sleep. - March 12, 2009 - EarthPulse Tech, LLC
Baxa Corporation Launches “Culture of Safety” Campaign to Recognize National Patient Safety Awareness Week
New Baxa Corporation campaign targets push towards cultural changes that promote patient safety. The campaign is timed to launch during National Patient Safety Awareness Week, March 8-14, targeting both pharmacy and nursing staff in U.S. hospitals. - March 12, 2009 - Baxa Corporation
IonSense Announces the Greening of DART® Ion Source Technology
iPod Enabled Controller Facilitates Analysis with Nitrogen Gas, Simplifying Operation and Reducing Generation of Waste Products. - March 08, 2009 - IonSense, Inc.
MDS Nordion to Host Physician Expert Teams from Banner Good Samaritan Medical Center and UNC School of Medicine at SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
MDS Nordion to Demonstrate Improved TheraSphere® Administration System During SIR 2009
MDS Nordion event information for the Society of Interventional Radiology 2009 Scientific Meeting. - March 07, 2009 - MDS Nordion
Quintiles Named to Training Top 125 for Workforce Training and Development Excellence
Quintiles Transnational Corp., the world’s largest pharmaceutical services company, has been named to TRAINING magazine’s “Training Top 125,” the publication’s annual report that ranks companies based on their employer-sponsored training and development... - March 06, 2009 - Quintiles
Quantimetrix Corporation Releases New Package Design
Quantimetrix Corporation announces its newly redesigned product packaging. - March 05, 2009 - Quantimetrix Corporation
Genescient and Kronos Announce Alzheimer's Disease Collaboration
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer's Disease. - March 04, 2009 - Genescient Corporation
Baxa Corporation Acquires Florida-Based ForHealth Technologies™
Baxa Corporation, a leading developer of technology for the safe handling, packaging and administration of fluid medications, today announced that it has acquired ForHealth Technologies, Inc., a Florida-based healthcare robotics and software company. The ForHealth acquisition adds IntelliFill i.v.® and IntelliFlowRx™ to the existing Baxa products for pharmacy operations management. - March 03, 2009 - Baxa Corporation